5 Most Promising Cancer Stocks According to Analysts

2. Kura Oncology, Inc. (NASDAQ:KURA)

Latest Analyst Share Price Upside: 128.05%

Kura Oncology, Inc. (NASDAQ:KURA) is a biotechnology firm developing treatments for leukemia, tumors, and liver disorders. The firm scored a win in December 2023 when its leukemia treatment allowed it to team with a major blood cancer research funder to further develop the drug.

During 2023’s third quarter, 21 out of the 910 hedge funds covered by Insider Monkey’s research had invested in the company. Kura Oncology, Inc. (NASDAQ:KURA)’s largest shareholder in our database is Aaron Cowen’s Suvretta Capital Management as it holds $66.9 million worth of shares.

Follow Kura Oncology Inc. (NASDAQ:KURA)